The third installment in our series, Conversations with Portia Combow: After being incorrectly diagnosed, first with a staph infection and then with folliculitis – Portia discusses her experience and the treatment options she pursued prior to getting correctly diagnosed with Hidradenitis Suppurativa. The full webinar/conversation will be available soon, but in the interim, feel free…
“How long did it take to get your diagnosis?” is the next topic in our series, Living with HS – conversations with Portia Combow. As Thalocan continues to work to improve the process of disease assessment in clinical research, we are grateful to Portia as she shares her unique and first-hand experience with Hidradenitis Suppurativa.…
Meet Portia Combow, who has battled Hidradenitis Suppurativa (HS) for nearly two decades. Portia has been generous enough to share her experiences around the stigma, her long journey to diagnosis, as well as her own discovery of disease management strategies. At Thalocan we work to improve the process of disease assessment in clinical research, the patient experience informs all…
To effectively address challenges in clinical trial endpoint management within the immuno-dermatology therapeutic area, a strong team is essential. We are proud to introduce the talented and driven individuals who make up Thalocan Research Innovations. Their expertise and dedication help our customers capture meaningful data to identify treatments that improve patients’ quality of life.
